Clinical trial
Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.
NCT03334682 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.
- Lead sponsor
- Nantes University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2018
- Completion date
- July 4, 2023
- Enrollment
- 158 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.